Belgium's Arseus sells units to U.S. group Henry Schein
BRUSSELS Jan 6 (Reuters) - Belgian healthcare group Arseus has sold several small units of its healthcare supplies business to U.S. group Henry Schein for 50 million euros ($68.07 million), the company said on Monday.
Arseus sold its dental software units Julie and Arseus Dental Lab as well as Arseus Dental Solutions Benelux and France Ouest, which have joint annual sales of about 70 million euros.
In August, Arseus said that it was considering options for the group's Healthcare Solutions and Healthcare Specialities divisions, after sales for these businesses fell in the first half.
The group had already disposed of its dental distribution activities in November and said on Monday it would make further announcements in the first half of 2014.
- Russia criticizes EU sanctions, raps U.S. over Ukraine role
- First Ebola victim in Sierra Leone capital on the run
- Short Gaza truce takes hold; many bodies pulled from rubble |
- Amazon's far-reaching ambitions, lack of profits, unnerve investors |
- Apple iPhones allow extraction of deep personal data, researcher finds